BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25139699)

  • 1. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
    Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
    Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.
    Carstensen-Kirberg M; Kannenberg JM; Huth C; Meisinger C; Koenig W; Heier M; Peters A; Rathmann W; Roden M; Herder C; Thorand B
    Cardiovasc Diabetol; 2017 Aug; 16(1):109. PubMed ID: 28851362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sfrp5 associates with beta-cell function in humans.
    Carstensen-Kirberg M; Hatziagelaki E; Tsiavou A; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M; Herder C
    Eur J Clin Invest; 2016 Jun; 46(6):535-43. PubMed ID: 27019073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
    Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
    J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease.
    Miyoshi T; Doi M; Usui S; Iwamoto M; Kajiya M; Takeda K; Nosaka K; Nakayama R; Okawa K; Takagi W; Nakamura K; Hirohata S; Ito H
    Atherosclerosis; 2014 Apr; 233(2):454-459. PubMed ID: 24530778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus.
    Lu YC; Wang CP; Hsu CC; Chiu CA; Yu TH; Hung WC; Lu LF; Chung FM; Tsai IT; Lin HC; Lee YJ
    Diabetes Metab Res Rev; 2013 Oct; 29(7):551-6. PubMed ID: 23653377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance.
    Hu Z; Deng H; Qu H
    Diabetes Res Clin Pract; 2013 Mar; 99(3):391-5. PubMed ID: 23290274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between pigment epithelium-derived factor, insulin resistance and high density lipoprotein.
    Pek S; Tavintharan S; Woon K; Niyati J; Lim SC; Sum CF
    Diabet Med; 2013 Sep; 30(9):1067-74. PubMed ID: 23600479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
    Liu J; Wang Y; Hu Y; Leng S; Wang G
    J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes.
    Gómez-Ambrosi J; Pascual E; Catalán V; Rodríguez A; Ramírez B; Silva C; Gil MJ; Salvador J; Frühbeck G
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2004-9. PubMed ID: 25050901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sfrp5 correlates with insulin resistance and oxidative stress.
    Carstensen M; Herder C; Kempf K; Erlund I; Martin S; Koenig W; Sundvall J; Bidel S; Kuha S; Roden M; Tuomilehto J
    Eur J Clin Invest; 2013 Apr; 43(4):350-7. PubMed ID: 23398169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children.
    Prats-Puig A; Soriano-Rodríguez P; Carreras-Badosa G; Riera-Pérez E; Ros-Miquel M; Gomila-Borja A; de Zegher F; Ibáñez L; Bassols J; López-Bermejo A
    Pediatr Res; 2014 Jun; 75(6):793-7. PubMed ID: 24603290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted Frizzled-Related Protein 5 (SFRP5) in Patients with Obstructive Sleep Apnea.
    Zhang DM; Huang R; Xiao Y; Gong FY; Zhong X; Luo JM
    Chin Med Sci J; 2017 Dec; 32(4):211-217. PubMed ID: 29301595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
    Nunez Lopez YO; Garufi G; Seyhan AA
    Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive association of free triiodothyronine with pancreatic β-cell function in people with prediabetes.
    Oda T; Taneichi H; Takahashi K; Togashi H; Hangai M; Nakagawa R; Ono M; Matsui M; Sasai T; Nagasawa K; Honma H; Kajiwara T; Takahashi Y; Takebe N; Ishigaki Y; Satoh J
    Diabet Med; 2015 Feb; 32(2):213-9. PubMed ID: 25255697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs7903146 Variant in the
    Cropano C; Santoro N; Groop L; Dalla Man C; Cobelli C; Galderisi A; Kursawe R; Pierpont B; Goffredo M; Caprio S
    Diabetes Care; 2017 Aug; 40(8):1082-1089. PubMed ID: 28611053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.
    Yang SJ; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1325-9. PubMed ID: 21677040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.
    Fiorentino TV; Andreozzi F; Mannino GC; Pedace E; Perticone M; Sciacqua A; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4030-4038. PubMed ID: 27459528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.